tiprankstipranks
Alkermes Reveals Promising Phase 1b Study Results
PremiumCompany AnnouncementsAlkermes Reveals Promising Phase 1b Study Results
10d ago
Alkermes’ ALKS 2680 improves wakefulness in Phase 1b narcolepsy study
PremiumThe Fly
Alkermes’ ALKS 2680 improves wakefulness in Phase 1b narcolepsy study
10d ago
Alkermes presents results from long-term safety study of LYBALVI
PremiumThe Fly
Alkermes presents results from long-term safety study of LYBALVI
11d ago
Alkermes Expands Board, Elects Nancy Lurker as New Director
PremiumCompany AnnouncementsAlkermes Expands Board, Elects Nancy Lurker as New Director
1M ago
Alkermes downgraded to Sell from Neutral at UBS
PremiumThe Fly
Alkermes downgraded to Sell from Neutral at UBS
2M ago
Alkermes price target raised to $33 from $30 at BofA
PremiumThe Fly
Alkermes price target raised to $33 from $30 at BofA
2M ago
ALKS Earnings this Week: How Will it Perform?
PremiumPre-EarningsALKS Earnings this Week: How Will it Perform?
2M ago
Alkermes Announces Interim Financial Leadership Appointments
PremiumCompany Announcements
Alkermes Announces Interim Financial Leadership Appointments
2M ago
Alkermes reports results from Phase 3 study of LYBALVI
PremiumThe Fly
Alkermes reports results from Phase 3 study of LYBALVI
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100